Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ragweed-SPIRE in Ragweed Allergic Subjects
NCT02061709Phase 2Completed
- Sponsor
- NIOX Group
- Start
- Jan 2014
- Primary completion
- Oct 2014
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ragweed-spire in seasonal allergic rhinitis (SAR), sponsored by NIOX Group. Started Jan 2014; status: completed.
02
Drugs
ragweed-spire
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT02061709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061709.